Echocardiographic predictors of mitral stenosis-related death or intervention in infants

Elif Seda Selamet Tierney1, Dionne A Graham, Doff B McElhinney

  • 1Department of Cardiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02155, USA. seda.tierney@cardio.chboston.org

Abstract

Insights

In infants with congenital mitral stenosis (MS), a higher mean mitral valve inflow gradient and shorter left ventricular (LV) length on echocardiography predict worse outcomes, including death or intervention. Mitral valve morphology was not a predictor.

Area of Science:

  • Pediatric Cardiology
  • Echocardiography
  • Congenital Heart Disease

Background:

  • Congenital mitral stenosis (MS) is a rare condition with variable prognosis.
  • Echocardiographic predictors of adverse outcomes in infants with MS are not well-defined.

Purpose of the Study:

  • To identify independent echocardiographic predictors of mitral stenosis (MS)-related death or intervention in infants.
  • To determine factors associated with MS-related outcomes in early infancy.

Main Methods:

  • Retrospective review of clinical and echocardiographic data from 71 infants diagnosed with MS before 6 months of age.
  • Analysis of initial echocardiographic variables to identify predictors of a composite endpoint of mitral valve (MV) intervention or MS-related death.

Main Results:

  • Higher initial MV mean inflow gradient and lower LV diastolic length Z-score were significant predictors of intervention or death.
  • An MV inflow gradient >= 5.5 mm Hg was associated with an 85% risk of adverse outcomes.
  • An LV diastolic length Z-score <= 0 predicted a higher endpoint rate in patients with intermediate gradients.

Conclusions:

  • In infants with congenital MS, elevated mean MV inflow gradient and shorter LV length are associated with increased risk.
  • Mitral valve morphology does not predict outcomes in this population.
  • Echocardiography provides crucial prognostic information for guiding management in infantile MS.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...